- $312.40m
- $203.60m
- $92.39m
Brief: Prenetics Global Says Aryna Sabalenka Expands Her Stake In Prenetics
Prenetics tumbles on $48 mln stock-and-warrants offering to expand, buy bitcoin
Prenetics tumbles after launching stock-and-warrants offering
DNA test provider Prenetics jumps after lifting annual forecast
DNA tests provider Prenetics Global's Q2 revenue up 594.9%, shares jump
Brief: Prenetics Global Ltd Files For Mixed Shelf Of Up To $1 Bln – SEC Filing
Brief: Prenetics Announces Third Quarter 2024 Financial Results
Brief: Prenetics Announces Second Quarter 2024 Financial Results
Brief: Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham
Brief: Prenetics Global Says David Beckham Has Become A Strategic Investor In Co
Brief: Prenetics Welcomes Kathyrn Henry And David Vanderveen To Board Of Directors
Brief: Prenetics Global Ltd Says It Regains Compliance With Nasdaq Minimum Bid Price Requirement
Brief: Prenetics Announces Third Quarter 2023 Financial Results
Brief: Berry Genomics Says Board Agrees Co To Sell Stakes In Prenetics Global
Brief: Prenetics Global Announces Reverse Stock Split
Brief: Prenetics Global Ltd Received Notification Regarding Minimum Bid Price Deficiency From Nasdaq
Brief: Prenetics Global Announces First Quarter 2023 Results
Brief: Prenetics Announces Fourth Quarter, Full Year 2022 Financial Results
Brief: Prenetics Announces Dr. Bayju Thakar As Chief Executive Officer Of Prenetics EMEA